These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 10556107)
21. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF; Miravitlles M Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Stockley RA; Parr DG; Piitulainen E; Stolk J; Stoel BC; Dirksen A Respir Res; 2010 Oct; 11(1):136. PubMed ID: 20920370 [TBL] [Abstract][Full Text] [Related]
24. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency. Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966 [TBL] [Abstract][Full Text] [Related]
25. Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency. Fuchs SI; Schwerk N; Pittschieler K; Ahrens F; Baden W; Bals R; Fähndrich S; Gleiber W; Griese M; Hülskamp G; Köhnlein T; Reckling L; Rietschel E; Staab D; Gappa M Respir Med; 2016 Jul; 116():93-9. PubMed ID: 27296827 [TBL] [Abstract][Full Text] [Related]
26. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950 [TBL] [Abstract][Full Text] [Related]
28. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin]. Wencker M; Banik N; Buhl R; Seidel R; Konietzko N Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632 [TBL] [Abstract][Full Text] [Related]
29. Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers. Mohamed Hoesein FA; Zanen P; van Ginneken B; van Klaveren RJ; Lammers JW Eur Respir J; 2011 Nov; 38(5):1012-8. PubMed ID: 21565924 [TBL] [Abstract][Full Text] [Related]
30. Lung density associates with survival in alpha 1 antitrypsin deficient patients. Green CE; Parr DG; Edgar RG; Stockley RA; Turner AM Respir Med; 2016 Mar; 112():81-7. PubMed ID: 26874894 [TBL] [Abstract][Full Text] [Related]
31. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency. Sandhaus RA Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674 [TBL] [Abstract][Full Text] [Related]
32. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency. Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322 [TBL] [Abstract][Full Text] [Related]
33. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency]. Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165 [TBL] [Abstract][Full Text] [Related]
36. Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Dawkins PA; Dawkins CL; Wood AM; Nightingale PG; Stockley JA; Stockley RA Eur Respir J; 2009 Jun; 33(6):1338-44. PubMed ID: 19164359 [TBL] [Abstract][Full Text] [Related]
37. The direct medical costs of alpha(1)-antitrypsin deficiency. Mullins CD; Huang X; Merchant S; Stoller JK; Chest; 2001 Mar; 119(3):745-52. PubMed ID: 11243952 [TBL] [Abstract][Full Text] [Related]
38. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient. Mal H; Guignabert C; Thabut G; d'Ortho MP; Brugière O; Dauriat G; Marrash-Chahla R; Rangheard AS; Lesèche G; Fournier M Am J Respir Crit Care Med; 2004 Oct; 170(7):811-4. PubMed ID: 15184198 [TBL] [Abstract][Full Text] [Related]
39. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Tonelli AR; Rouhani F; Li N; Schreck P; Brantly ML Int J Chron Obstruct Pulmon Dis; 2009; 4():443-52. PubMed ID: 20054436 [TBL] [Abstract][Full Text] [Related]
40. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD. Vijayasaratha K; Stockley RA Int J Chron Obstruct Pulmon Dis; 2012; 7():789-96. PubMed ID: 23226015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]